These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 31170527

  • 1. Thermoplastic polyurethane as matrix forming excipient using direct and ultrasound-assisted compression.
    Casas M, Galdón E, Ojeda DJ, Caraballo I.
    Eur J Pharm Sci; 2019 Aug 01; 136():104949. PubMed ID: 31170527
    [Abstract] [Full Text] [Related]

  • 2. Achieving High Excipient Efficiency with Elastic Thermoplastic Polyurethane by Ultrasound Assisted Direct Compression.
    Galdón E, Casas M, Caraballo I.
    Pharmaceutics; 2019 Apr 02; 11(4):. PubMed ID: 30987006
    [Abstract] [Full Text] [Related]

  • 3. A comparative study between melt granulation/compression and hot melt extrusion/injection molding for the manufacturing of oral sustained release thermoplastic polyurethane matrices.
    Verstraete G, Mertens P, Grymonpré W, Van Bockstal PJ, De Beer T, Boone MN, Van Hoorebeke L, Remon JP, Vervaet C.
    Int J Pharm; 2016 Nov 20; 513(1-2):602-611. PubMed ID: 27686052
    [Abstract] [Full Text] [Related]

  • 4. A new biodegradable polythiourethane as controlled release matrix polymer.
    Campiñez MD, Ferris C, de Paz MV, Aguilar-de-Leyva A, Galbis J, Caraballo I.
    Int J Pharm; 2015 Mar 01; 480(1-2):63-72. PubMed ID: 25579868
    [Abstract] [Full Text] [Related]

  • 5. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes.
    Verstraete G, Samaro A, Grymonpré W, Vanhoorne V, Van Snick B, Boone MN, Hellemans T, Van Hoorebeke L, Remon JP, Vervaet C.
    Int J Pharm; 2018 Jan 30; 536(1):318-325. PubMed ID: 29217471
    [Abstract] [Full Text] [Related]

  • 6. A new deferiprone controlled release system obtained by ultrasound-assisted compression.
    Aguilar-De-Leyva A, Gonçalves-Araujo T, Daza V, Caraballo I.
    Pharm Dev Technol; 2014 Sep 30; 19(6):728-34. PubMed ID: 23984972
    [Abstract] [Full Text] [Related]

  • 7. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
    Hsein H, Garrait G, Tamani F, Beyssac E, Hoffart V.
    Pharm Res; 2017 Feb 30; 34(2):365-377. PubMed ID: 28004316
    [Abstract] [Full Text] [Related]

  • 8. Development and characterization of new functionalized polyurethanes for sustained and site-specific drug release in the gastrointestinal tract.
    Campiñez MD, Benito E, Romero-Azogil L, Aguilar-de-Leyva Á, García-Martín MG, Galbis JA, Caraballo I.
    Eur J Pharm Sci; 2017 Mar 30; 100():285-295. PubMed ID: 28108361
    [Abstract] [Full Text] [Related]

  • 9. Nano-silver-incorporated biomimetic polydopamine coating on a thermoplastic polyurethane porous nanocomposite as an efficient antibacterial wound dressing.
    Liu M, Liu T, Chen X, Yang J, Deng J, He W, Zhang X, Lei Q, Hu X, Luo G, Wu J.
    J Nanobiotechnology; 2018 Nov 12; 16(1):89. PubMed ID: 30419925
    [Abstract] [Full Text] [Related]

  • 10. Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
    Claeys B, Vervaeck A, Hillewaere XK, Possemiers S, Hansen L, De Beer T, Remon JP, Vervaet C.
    Eur J Pharm Biopharm; 2015 Feb 12; 90():44-52. PubMed ID: 25448075
    [Abstract] [Full Text] [Related]

  • 11. Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets?
    Košir D, Ojsteršek T, Vrečer F.
    Drug Dev Ind Pharm; 2018 Sep 12; 44(9):1543-1550. PubMed ID: 29848075
    [Abstract] [Full Text] [Related]

  • 12. Novel Polyurethane Matrix Systems Reveal a Particular Sustained Release Behavior Studied by Imaging and Computational Modeling.
    Campiñez MD, Caraballo I, Puchkov M, Kuentz M.
    AAPS PharmSciTech; 2017 Jul 12; 18(5):1544-1553. PubMed ID: 27600323
    [Abstract] [Full Text] [Related]

  • 13. Study of the properties of the new biodegradable polyurethane PU (TEG-HMDI) as matrix forming excipient for controlled drug delivery.
    Campiñez MD, Aguilar-de-Leyva Á, Ferris C, de Paz MV, Galbis JA, Caraballo I.
    Drug Dev Ind Pharm; 2013 Nov 12; 39(11):1758-64. PubMed ID: 24087856
    [Abstract] [Full Text] [Related]

  • 14. Towards a rational basis for selection of excipients: Excipient Efficiency for controlled release.
    Casas M, Aguilar-de-Leyva Á, Caraballo I.
    Int J Pharm; 2015 Oct 15; 494(1):288-95. PubMed ID: 26253376
    [Abstract] [Full Text] [Related]

  • 15. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.
    Miranda A, Millán M, Caraballo I.
    J Pharm Sci; 2007 Oct 15; 96(10):2746-56. PubMed ID: 17506514
    [Abstract] [Full Text] [Related]

  • 16. Hydrophilic thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding.
    Verstraete G, Van Renterghem J, Van Bockstal PJ, Kasmi S, De Geest BG, De Beer T, Remon JP, Vervaet C.
    Int J Pharm; 2016 Jun 15; 506(1-2):214-21. PubMed ID: 27113866
    [Abstract] [Full Text] [Related]

  • 17. Floating matrix tablets based on low density foam powder: effects of formulation and processing parameters on drug release.
    Streubel A, Siepmann J, Bodmeier R.
    Eur J Pharm Sci; 2003 Jan 15; 18(1):37-45. PubMed ID: 12554071
    [Abstract] [Full Text] [Related]

  • 18. Percolation thresholds in ultrasound compacted tablets.
    Caraballo I, Millán M, Fini A, Rodriguez L, Cavallari C.
    J Control Release; 2000 Dec 03; 69(3):345-55. PubMed ID: 11102675
    [Abstract] [Full Text] [Related]

  • 19. Application of the SeDeM Expert System in Studies for Direct Compression Suitability on Mixture of Rhodiola Extract and an Excipient.
    Wan S, Yang R, Zhang H, Li X, Gu M, Guan T, Ren J, Sun H, Dai C.
    AAPS PharmSciTech; 2019 Feb 11; 20(3):105. PubMed ID: 30746569
    [Abstract] [Full Text] [Related]

  • 20. Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system.
    Aguilar-Díaz JE, García-Montoya E, Suñe-Negre JM, Pérez-Lozano P, Miñarro M, Ticó JR.
    Eur J Pharm Biopharm; 2012 Apr 11; 80(3):638-48. PubMed ID: 22245156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.